Litigation Details for SUMITOMO DAINIPPON PHARMA CO., LTD. v. EMCURE PHARMACEUTICALS LIMITED (D.N.J. 2015)
✉ Email this page to a colleague
SUMITOMO DAINIPPON PHARMA CO., LTD. v. EMCURE PHARMACEUTICALS LIMITED (D.N.J. 2015)
| Docket | ⤷ Try a Trial | Date Filed | 2015-01-13 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-02-27 |
| Cause | 35:145 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Patents | 10,183,006 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SUMITOMO DAINIPPON PHARMA CO., LTD. v. EMCURE PHARMACEUTICALS LIMITED
The small molecule drug covered by the patent cited in this case is ⤷ Try a Trial .
Details for SUMITOMO DAINIPPON PHARMA CO., LTD. v. EMCURE PHARMACEUTICALS LIMITED (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-08-16 | 100 | claim was limited to a racemic mixture. (Exh. 10, 183:6-200:21.) This is the opposite of what the district…acknowledge the ’372 patent’s important teaching that Example 1 of the patent is a “preferred embodiment… studying Claim 14, the ’372 patent specification, and the ’372 patent file history, each of the Defendants… of the ’372 patent demonstrates that any restriction requirement issued during patent prosecution did…the patent claim at issue in the Pfizer v. Ranbaxy action and the key language from the patent specification | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
